This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.64% per year. These returns cover a period from January 1, 1988 through August 4, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
UnitedHealth Group, Inc. is the largest health care services company in the world, serving over 50 million individuals in the United States as of 2019 and over 5 million internationally. The company provides a wide range of health care products and services, such as health maintenance organizations (HMOs), point of service plans (POS), preferred provider organizations (PPOs), and managed fee-for-service programs. UnitedHealth has the largest and most diverse membership base within the managed-care organization market, which gives it significant competitive advantages. It also has built its prescription drug business through OptumRx division, with the acquisition of Catamaran in 2015.
UnitedHealth Group Incorporated (UNH) Is a Trending Stock: Facts to Know Before Betting on It
by Zacks Equity Research
UnitedHealth (UNH) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
The Zacks Analyst Blog Tesla, UnitedHealth Group, Oracle and Earth Science Tech
by Zacks Equity Research
Tesla, UnitedHealth Group, Oracle and Earth Science Tech are included in this Analyst Blog.
Top Research Reports for Tesla, UnitedHealth & Oracle
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including Tesla, Inc. (TSLA), UnitedHealth Group Incorporated (UNH) and Oracle Corporation (ORCL), as well as a micro-cap stock Earth Science Tech, Inc. (ETST).
Elevance Health's Q4 Earnings Beat Estimates on Rising Premiums
by Zacks Equity Research
ELV's fourth-quarter results benefit from rising premiums. However, higher expenses and attrition in Medicaid membership partially offset the positives.
Is UnitedHealth a Buy After Q4 Domestic Commercial Membership Growth?
by Kaibalya Pravo Dey
UNH's Optum Health is expected to serve about 5.4 million value-based care patients in 2025.
ETFs in Focus Post UnitedHealth's Mixed Q4 Results
by Sweta Killa
UnitedHealth breezes past the Zacks Consensus Estimate for earnings but misses the same for revenues.
Stock Market News for Jan 17, 2025
by Zacks Equity Research
Wall Street closed lower on Thursday as market participants assessed economic data that signaled a resilient U.S. economy.
Mixed Bag for UnitedHealth: Q4 Earnings Beat, Revenues Fall Short
by Zacks Equity Research
UNH projects revenues between $450 billion and $455 billion for 2025.
UnitedHealth (UNH) Reports Q4 Earnings: What Key Metrics Have to Say
by Zacks Equity Research
While the top- and bottom-line numbers for UnitedHealth (UNH) give a sense of how the business performed in the quarter ended December 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Will UNH, HUM & CVS be the Top Beneficiaries of the $21B MA Boom?
by Kaibalya Pravo Dey
The government's payment rate directly impacts insurers' pricing, plan benefits and overall profitability.
UnitedHealth Group (UNH) Beats Q4 Earnings Estimates
by Zacks Equity Research
UnitedHealth (UNH) delivered earnings and revenue surprises of 1.49% and 1.41%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?
Top Research Reports for Visa, AbbVie & Analog Devices
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Visa Inc. (V), AbbVie Inc. (ABBV) and Analog Devices, Inc. (ADI), as well as a micro-cap stock Precipio, Inc. (PRPO).
FTC Report Reveals PBM Practices Impacting Competition and Drug Costs
by Zacks Equity Research
The report comes at a time when insurers are grappling with rising medical costs.
5 Stocks You Must Watch for Earnings This Week
by Tracey Ryniec
Hint: They aren't all banks.
What Lies Ahead for Dow ETF in Q4 Earnings?
by Sweta Killa
The Dow Jones is performing better amid the rise in Treasury yields and the tech sell-off. The trend might continue as we head into the fourth-quarter earnings season.
Stock Market News for Jan 14, 2025
by Zacks Equity Research
Wall Street closed mixed on Monday, driven by energy and healthcare stocks.
Big Gains Ahead for Medicare Advantage Sellers as Payments Set to Grow
by Kaibalya Pravo Dey
As the largest MA plan sellers, UnitedHealth, Humana and CVS Health collectively account for nearly 60% of the market.
Should Vanguard Value ETF (VTV) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for VTV
What Analyst Projections for Key Metrics Reveal About UnitedHealth (UNH) Q4 Earnings
by Zacks Equity Research
Evaluate the expected performance of UnitedHealth (UNH) for the quarter ended December 2024, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.
UnitedHealth Stock Q4 Earnings Preview: Buy Now or Wait for Results?
by Kaibalya Pravo Dey
UNH's fourth-quarter earnings are likely to have benefited from growing premiums and service revenues.
Zacks Industry Outlook Highlights UnitedHealth, Humana and Centene
by Zacks Equity Research
UnitedHealth, Humana and Centene have been highlighted in this Industry Outlook article.
Will UnitedHealth (UNH) Beat Estimates Again in Its Next Earnings Report?
by Zacks Equity Research
UnitedHealth (UNH) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
3 HMO Stocks Poised to Thrive Despite Industry Headwinds
by Debasmita Chatterjee
The Medical-HMO industry benefits from a growing customer base and contract wins. However, industry challenges like rising costs and workforce shortages remain a concern. UNH, HUM and CNC are likely to navigate industry storms.
Why Investors Need to Take Advantage of These 2 Medical Stocks Now
by Zacks Equity Research
Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.
Stock Market News for Jan 10, 2025
by Zacks Equity Research
Wall Street remains volatile since the beginning of 2025.